Mexico
· Delayed Price · Currency is MXN Sarepta Therapeutics Statistics
Total Valuation
BMV:SRPT has a market cap or net worth of MXN 70.19 billion. The enterprise value is 86.57 billion.
| Market Cap | 70.19B |
| Enterprise Value | 86.57B |
Important Dates
The last earnings date was Tuesday, May 6, 2025.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 98.28M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.83% |
| Shares Change (QoQ) | -10.24% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 93.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 6.33 |
| PS Ratio | 1.54 |
| PB Ratio | 3.01 |
| P/TBV Ratio | 3.08 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 128.83, with an EV/FCF ratio of -6.09.
| EV / Earnings | -17.05 |
| EV / Sales | 1.97 |
| EV / EBITDA | 128.83 |
| EV / EBIT | n/a |
| EV / FCF | -6.09 |
Financial Position
The company has a current ratio of 4.02, with a Debt / Equity ratio of 1.19.
| Current Ratio | 4.02 |
| Quick Ratio | 2.06 |
| Debt / Equity | 1.19 |
| Debt / EBITDA | 39.65 |
| Debt / FCF | -1.95 |
| Interest Coverage | -6.26 |
Financial Efficiency
Return on equity (ROE) is -23.61% and return on invested capital (ROIC) is -3.02%.
| Return on Equity (ROE) | -23.61% |
| Return on Assets (ROA) | -2.19% |
| Return on Invested Capital (ROIC) | -3.02% |
| Return on Capital Employed (ROCE) | -4.10% |
| Revenue Per Employee | 33.27M |
| Profits Per Employee | -3.70M |
| Employee Count | 1,372 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 2.71 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1,742.86 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 7.51 |
| Average Volume (20 Days) | 56 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.26 |
Income Statement
In the last 12 months, BMV:SRPT had revenue of MXN 45.65 billion and -5.08 billion in losses. Loss per share was -52.93.
| Revenue | 45.65B |
| Gross Profit | 9.19B |
| Operating Income | -2.40B |
| Pretax Income | -3.36B |
| Net Income | -5.08B |
| EBITDA | -1.60B |
| EBIT | -2.40B |
| Loss Per Share | -52.93 |
Balance Sheet
The company has 10.68 billion in cash and 27.73 billion in debt, giving a net cash position of -17.05 billion.
| Cash & Cash Equivalents | 10.68B |
| Total Debt | 27.73B |
| Net Cash | -17.05B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 23.36B |
| Book Value Per Share | 237.71 |
| Working Capital | 37.34B |
Cash Flow
In the last 12 months, operating cash flow was -11.18 billion and capital expenditures -3.03 billion, giving a free cash flow of -14.21 billion.
| Operating Cash Flow | -11.18B |
| Capital Expenditures | -3.03B |
| Free Cash Flow | -14.21B |
| FCF Per Share | n/a |
Margins
Gross margin is 20.14%, with operating and profit margins of -5.25% and -11.12%.
| Gross Margin | 20.14% |
| Operating Margin | -5.25% |
| Pretax Margin | -7.35% |
| Profit Margin | -11.12% |
| EBITDA Margin | -3.50% |
| EBIT Margin | -5.25% |
| FCF Margin | n/a |
Dividends & Yields
BMV:SRPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.83% |
| Shareholder Yield | -0.83% |
| Earnings Yield | -7.23% |
| FCF Yield | -20.25% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BMV:SRPT has an Altman Z-Score of 2.33. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.33 |
| Piotroski F-Score | n/a |